The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Flaum Sander A since year 2005.
The trader's CIK number is 1261026.
At the time of the last reporting, Flaum Sander A was the Director of Eagle Pharmaceuticals, Inc. .
(stock ticker symbol EGRX).
See this page for all insider trading activities at Eagle Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-05||EGRX||Eagle Pharmaceuticals, Inc.||Option Ex||2,340||4.04||9,453|
|2018-03-06||EGRX||Eagle Pharmaceuticals, Inc.||Sale||2,340||53.94||126,219|
|2018-03-05||EGRX||Eagle Pharmaceuticals, Inc.||Option Ex||2,340||.90||2,106|
|2016-11-28||EGRX||Eagle Pharmaceuticals, Inc.||Sale||5,000||78.66||393,300|
|2015-03-20||EGRX||Eagle Pharmaceuticals, Inc.||Sale||9,800||42.00||411,600|
|2015-12-22||EGRX||Eagle Pharmaceuticals, Inc.||Sale||3,225||93.75||302,359|
|2007-06-28||VAS||Viasys Healthcare Inc||Option Ex||8,088||22.28||180,168|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flaum Sander A (Director of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.